Matthew T Keeney, Eric K Hoffman, Kyle Farmer, Christopher R Bodle, Marco Fazzari, Alevtina Zharikov, Sandra L Castro, Xiaoping Hu, Amanda Mortimer, Julia K Kofler, Eugenia Cifuentes-Pagano, Patrick J Pagano, Edward A Burton, Teresa G Hastings, J Timothy Greenamyre, Roberto Di Maio
Mitochondrial dysfunction and oxidative stress are strongly implicated in Parkinson's disease (PD) pathogenesis and there is evidence that mitochondrially-generated superoxide can activate NADPH oxidase 2 (NOX2). Although NOX2 has been examined in the context of PD, most attention has focused on glial NOX2, and the role of neuronal NOX2 in PD remains to be defined. Additionally, pharmacological NOX2 inhibitors have typically lacked specificity. Here we devised and validated a proximity ligation assay for NOX2 activity and demonstrated that in human PD and two animal models thereof, both neuronal and microglial NOX2 are highly active in substantia nigra under chronic conditions...
August 2022: Neurobiology of Disease